Skip to main content
. 2017 Dec 26;318(24):2438–2445. doi: 10.1001/jama.2017.19343

Table 2. Unadjusted Results for Surgical Site Infection (SSI) Within 30 Days After Removal of Orthopedic Implants.

No. of Patients With an SSI (%) Absolute Risk Difference,
% (95% CI)
Cefazolin Group
(n = 228)
Saline Group
(n = 242)
SSIa 30 (13.2) 36 (14.9) −1.7 (−8.0 to 4.6)
Superficial 29 (12.7) 29 (12.0) 0.7 (−5.3 to 6.8)
Deep 1 (0.4) 7 (2.9) −2.5 (−5.7 to 0.4)
a

Primary outcome measure.